BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.376,73 PKT -7,97 PKT -0,58 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
26.09.17 ABB (Asea Brown Boveri) Neutral Goldman Sachs Group Inc.
26.09.17 UBS Hold Deutsche Bank AG
26.09.17 UBS buy Deutsche Bank AG
26.09.17 Nestlé buy UBS AG
26.09.17 Nestlé buy Kepler Cheuvreux
26.09.17 Holcim Hold Deutsche Bank AG
25.09.17 Roche Underperform BNP PARIBAS
25.09.17 UBS buy UBS AG
25.09.17 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
25.09.17 Roche overweight JP Morgan Chase & Co.
22.09.17 Nestlé overweight Morgan Stanley
22.09.17 Givaudan Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.09.17 Nestlé Hold Jefferies & Company Inc.
21.09.17 Roche buy Jefferies & Company Inc.
21.09.17 Swiss Re Neutral Citigroup Corp.
21.09.17 Roche Conviction Buy List Goldman Sachs Group Inc.
20.09.17 Givaudan Neutral Goldman Sachs Group Inc.
20.09.17 Nestlé Underperform Credit Suisse Group
20.09.17 Swiss Re Sector Perform RBC Capital Markets
19.09.17 Novartis kaufen HSBC
18.09.17 Givaudan Neutral UBS AG
18.09.17 Swiss Re Sell UBS AG
18.09.17 Swiss Re buy Deutsche Bank AG
18.09.17 UBS buy Goldman Sachs Group Inc.
18.09.17 UBS Neutral Goldman Sachs Group Inc.
15.09.17 UBS overweight JP Morgan Chase & Co.
15.09.17 UBS overweight JP Morgan Chase & Co.
15.09.17 Roche Reduce HSBC
15.09.17 UBS buy HSBC
15.09.17 UBS buy HSBC
14.09.17 Swiss Re buy Deutsche Bank AG
13.09.17 Nestlé overweight JP Morgan Chase & Co.
13.09.17 Roche overweight Barclays Capital
13.09.17 Roche overweight JP Morgan Chase & Co.
13.09.17 Zurich Insurance Sector Perform RBC Capital Markets
13.09.17 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
12.09.17 Roche Hold Baader Bank
12.09.17 Swiss Re overweight JP Morgan Chase & Co.
12.09.17 UBS overweight JP Morgan Chase & Co.
12.09.17 Zurich Insurance overweight JP Morgan Chase & Co.